PARIS, July 29, 2016 /PRNewswire/ --
Sanofi, a global and diversified healthcare leader, reports
results for the second quarter of 2016. CEO Olivier Brandicourt comments on the results.
Watch video interview and read
transcript:
http://www.eurobusinessmedia.com/ceo-direct/sanofi/q2-2016-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire
Topics covered in the interview
include:
- Q2 highlights
- Diabetes
- Praluent(R)
- Dengvaxia(R)
- CHC
- R&D
- Outlook
About Sanofi
Sanofi, a global healthcare leader, discovers, develops and
distributes therapeutic solutions focused on patients' needs.
Sanofi is organized into five global business units: Diabetes and
Cardiovascular, General Medicines and Emerging Markets, Sanofi
Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in
Paris (EURONEXT: SAN) and in
New York (NYSE: SNY).
SOURCE Sanofi